Multiple Myeloma

Latest News in Multiple Myeloma

June 6, 2024

Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma – nejm.org

June 3, 2024

Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma – nejm.org

June 3, 2024

Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial – Nature.com

June 1, 2024

Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma – nejm.org

May 23, 2024

Dr. C. Ola Landgren on Quadruple Therapies and the Future of Multiple Myeloma Treatment – University of Miami

688 Active Multiple Myeloma Clinical Trials

As of November 12, 2024

Source: clinicaltrials.gov

LOCATE

CLINICAL TRIALS

BROWSE

FDA-approved DRUGS

FIND

A DOCTOR EXPERT™

WHAT IS

CONGRESS DOING?